Related Experiment Video
Updated: Apr 16, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
8.3K
Gene therapy strategies to block HIV-1 replication by RNA interference
Elena Herrera-Carrillo1, Ben Berkhout
1Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, K3-110 Meibergdreef 15, Amsterdam, 1105 AS, The Netherlands.
Advances in Experimental Medicine and Biology
|March 12, 2015
Summary
RNA interference (RNAi) offers a durable gene therapy for persistent viral infections like HIV-1. Continuous expression of inhibitory RNA in T cells can effectively block viral replication, paving the way for new antiviral strategies.
Area of Science:
- * Molecular Biology
- * Virology
- * Gene Therapy
Background:
- * RNA interference (RNAi) is a cellular mechanism with antiviral properties.
- * Persistent viral infections, such as human immunodeficiency virus type 1 (HIV-1), necessitate durable therapeutic strategies.
- * Gene therapy approaches require continuous expression of inhibitory RNA molecules in target cells to effectively suppress viral replication.
Purpose of the Study:
- * To discuss the challenges and considerations for developing RNA interference-based gene therapies against persistent viral infections.
- * To explore optimal strategies for targeting viral RNA or host cofactors using RNAi.
- * To review the necessary preclinical testing systems for evaluating RNAi therapeutics.
Main Methods:
- * Review of existing literature on RNA interference mechanisms and antiviral applications.
- * Analysis of potential RNAi targets within the HIV-1 genome and host cofactors.
- * Discussion of various vector systems for sustained RNAi delivery.
- * Consideration of preclinical models for efficacy and safety testing.
Main Results:
- * RNAi presents a viable strategy for durable gene therapy against persistent viruses.
- * Successful implementation requires careful selection of RNAi inhibitors, target sequences, and delivery vectors.
- * Preclinical testing systems are crucial for validating therapeutic potential.
Conclusions:
- * RNA interference holds significant promise for developing novel gene therapies against persistent viral infections like HIV-1.
- * Strategic targeting and effective delivery systems are key to successful RNAi-based antiviral therapies.
- * Further research and preclinical validation are essential to translate RNAi strategies into clinical applications for chronic viral diseases.
Related Concept Videos
01:23RNA Interference
28.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.9K
01:23RNA Interference
7.9K
7.9K
02:15Experimental RNAi
8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
01:30Inhibitors of Viral Protein Synthesis
37
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
37
01:29Viruses with RNA Genomes
1.4K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.4K
02:30siRNA - Small Interfering RNAs
19.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.1K